CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension
Modar Kassan1, Andrea Wecker, Philip Kadowitz
1aDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia bDepartment of Pharmacology, Tulane University, New Orleans, Louisiana cCollege of Nanoscale Science and Engineering, University at Albany, Albany, New York, USA.
Journal of Hypertension
|July 25, 2013
Summary
Regulatory T cells impact cardiovascular health. This review explores their role in hypertension-induced vascular dysfunction and immune system imbalances.
Area of Science:
- Cardiovascular Physiology and Pathology
- Immunology
- Hypertension Research
Background:
- Endothelial dysfunction is central to cardiovascular disease development.
- Hypertension is linked to reduced vasodilator factors and endothelial dysfunction.
- Regulatory T cells are increasingly recognized for their cardiovascular roles.
Purpose of the Study:
- To review the role of regulatory T cells in hypertension-induced vascular dysfunction.
- To explore the connection between immune imbalance, inflammation, and cardiovascular homeostasis.
Main Methods:
- Literature review of recent evidence on regulatory T cells and hypertension.
- Analysis of immune system involvement in cardiovascular pathology.
Main Results:
- Regulatory T cells are implicated in cardiovascular physiology and pathology.
- Immune system imbalances can trigger inflammation, compromising cardiovascular homeostasis.
Conclusions:
- Regulatory T cells play a significant role in hypertension-induced vascular dysfunction.
- Understanding immune regulation is crucial for cardiovascular health in hypertension.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:18Neural Regulation of Blood Pressure
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...